Trade COLL stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Collegium Pharmaceutical, Inc. (COLL) is trading at US$21.53, down 2.36% today as of Oct 13, 16:00 EDT. The company has a market capitalisation of US$840.39M. Over the past 52 weeks, COLL has traded between US$21.43 and US$50.79. On Syfe you can trade COLL with $0 commission and add it to your watchlist.
| Previous close | US$22.05 |
|---|---|
| Market cap | US$840.39M |
| P/E ratio | 3.17 |
| 52-week range | US$21.43 – US$50.79 |
| Volume | 845.44K |
| Exchange | US |
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Year: 2015
Leerink Partners Initiates Coverage on Collegium Pharmaceutical With Outperform Rating, $45 Price Target
Sep 9, 11:53 AM · MT Newswires
Truist Cuts Price Target on Collegium Pharmaceutical to $49 From $58, Keeps Buy Rating
Sep 9, 11:27 AM · MT Newswires
Collegium Pharmaceutical, Inc. (COLL) stock is trading at US$21.53, -2.36% from the previous close of US$22.05.
The market cap for Collegium Pharmaceutical, Inc. (COLL) stock is approximately US$840.39M.
The price-to-earnings ratio for Collegium Pharmaceutical, Inc. (COLL) is 3.17, based on the latest reported earnings.
The 52-week high for Collegium Pharmaceutical, Inc. (COLL) stock is US$50.79.
The 52-week low for Collegium Pharmaceutical, Inc. (COLL) stock is US$21.43.
Collegium Pharmaceutical, Inc. (COLL) does not currently pay a dividend.
Stay on top of COLL
Price moves, news and earnings — straight to your inbox.
Snapshot
Popular Stocks in Singapore
